Ng Kenneth, Kedia Navin, Martin David, Tchou Patrick, Natale Andrea, Wilkoff Bruce, Starling Randall, Grimm Richard A
Division of Medicine, Department of Cardiovascular Medicine, The Cleveland Clinic, Cleveland, Ohio, USA.
Pacing Clin Electrophysiol. 2007 Feb;30(2):193-8. doi: 10.1111/j.1540-8159.2007.00649.x.
To identify subgroups of heart failure patients who might benefit from biventricular pacing.
Cardiac resynchronization therapy (CRT) improves the quality of life, New York Heart Association (NYHA) functional class, and exercise capacity and decreases hospitalizations for heart failure for patients who have severe heart failure and a wide QRS. It is unclear if other populations of heart failure patients would benefit from CRT.
One hundred forty-four consecutive heart failure patients who underwent CRT and completed 3 months of follow-up were reviewed. Demographic, echocardiographic, electrocardiographic, and clinical outcome data were analyzed to assess the relationship of functional class and QRS duration before device implantation to postimplant outcomes.
There were 20, 88, and 36 patients in NYHA functional class II, III, and IV, respectively. Thirty-four patients had right ventricular pacing and another 29 patients had a QRS duration < or = 150 ms. Patients who were in NYHA functional class II at baseline had significant improvement in left ventricular ejection fraction and indices of left ventricular remodeling after CRT. Similar significant findings were seen in the subgroup with right ventricular pacing at baseline after CRT. However, in the subgroup with a narrow QRS duration, there were no significant changes in the indices of left ventricular remodeling or in the NYHA functional class and there was a significant increase in the QRS duration. For the study cohort as a whole, an improvement in NYHA functional class after CRT correlated with a significant decrease in adverse clinical outcomes.
Heart failure patients who were in NYHA functional class II and those with right ventricular pacing appeared to benefit from CRT.
识别可能从双心室起搏中获益的心力衰竭患者亚组。
心脏再同步治疗(CRT)可改善重度心力衰竭且QRS波增宽患者的生活质量、纽约心脏协会(NYHA)心功能分级、运动能力,并减少因心力衰竭住院的次数。目前尚不清楚其他心力衰竭患者群体是否能从CRT中获益。
回顾了144例连续接受CRT并完成3个月随访的心力衰竭患者。分析人口统计学、超声心动图、心电图和临床结局数据,以评估植入装置前的心功能分级和QRS波时限与植入后结局之间的关系。
NYHA心功能分级为Ⅱ级、Ⅲ级和Ⅳ级的患者分别有20例、88例和36例。34例患者进行了右心室起搏,另外29例患者的QRS波时限≤150毫秒。基线时NYHA心功能分级为Ⅱ级的患者在CRT后左心室射血分数和左心室重构指标有显著改善。CRT后,基线时进行右心室起搏的亚组也有类似的显著发现。然而,在QRS波时限较窄的亚组中,左心室重构指标、NYHA心功能分级均无显著变化,且QRS波时限显著增加。对于整个研究队列,CRT后NYHA心功能分级的改善与不良临床结局的显著降低相关。
NYHA心功能分级为Ⅱ级的心力衰竭患者以及进行右心室起搏的患者似乎能从CRT中获益。